Perrigo | PRGO - Ordinary Share Capital



Perrigo reported $137.6M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
AbbVie USD 18M 0 Dec/2024
Abbott USD 25.12B 28M Mar/2025
Bayer EUR 982.42M 1.53B Jun/2025
Bristol-Myers Squibb USD 2.04B 1.74B Jun/2025
Corcept Therapeutics USD 105.29M 105.15M Jun/2025
Dr.Reddys Laboratories INR 834M 0 Mar/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
J&J USD 3.12B 0 Mar/2025
Merck USD 1.79B 0 Mar/2025
Nestle CHF 2.53B 2.27B Jun/2025
Pacira USD 44.9M 44.85M Jun/2025
Perrigo USD 137.6M 6.56B Jun/2025
Pfizer USD 5.68B 5.2B Jun/2025
Prestige Brands USD 49.21M 48.65M Jun/2025
Reckitt Benckiser GBP 74M 0 Dec/2024
Sanofi 1.22B 36.5M Jun/2025
Supernus Pharmaceuticals USD 56.12M 130K Jun/2025
Teva Pharmaceutical Industries USD 1.15B 1.09B Jun/2025
Xeris Pharmaceuticals USD 161.22M 161.21M Jun/2025
Zoetis USD 443.95M 438.95M Jun/2025